These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31267488)

  • 1. Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester.
    Sarkar A; Rawat N; Sachan N; Singh MP
    Neurotox Res; 2019 Oct; 36(3):627-644. PubMed ID: 31267488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
    Eidson LN; Kannarkat GT; Barnum CJ; Chang J; Chung J; Caspell-Garcia C; Taylor P; Mollenhauer B; Schlossmacher MG; Ereshefsky L; Yen M; Kopil C; Frasier M; Marek K; Hertzberg VS; Tansey MG
    J Neuroinflammation; 2017 Aug; 14(1):164. PubMed ID: 28821274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis.
    Parnetti L; Cicognola C; Eusebi P; Chiasserini D
    Biomark Med; 2016; 10(1):35-49. PubMed ID: 26643452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
    Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG
    J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid protein biomarkers in Parkinson's disease.
    Faizan M; Sachan N; Verma O; Sarkar A; Rawat N; Pratap Singh M
    Clin Chim Acta; 2024 Mar; 556():117848. PubMed ID: 38417781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF and blood biomarkers for Parkinson's disease.
    Parnetti L; Gaetani L; Eusebi P; Paciotti S; Hansson O; El-Agnaf O; Mollenhauer B; Blennow K; Calabresi P
    Lancet Neurol; 2019 Jun; 18(6):573-586. PubMed ID: 30981640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
    Atik A; Stewart T; Zhang J
    Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.
    Farotti L; Paciotti S; Tasegian A; Eusebi P; Parnetti L
    Expert Rev Mol Diagn; 2017 Aug; 17(8):771-780. PubMed ID: 28604235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
    Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
    Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
    Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
    Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.
    Eusebi P; Hansson O; Paciotti S; Orso M; Chiasserini D; Calabresi P; Blennow K; Parnetti L
    BMJ Open; 2017 Nov; 7(11):e018177. PubMed ID: 29170290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.
    Andersen AD; Binzer M; Stenager E; Gramsbergen JB
    Acta Neurol Scand; 2017 Jan; 135(1):34-56. PubMed ID: 26991855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease.
    Førland MG; Öhrfelt A; Dalen I; Tysnes OB; Blennow K; Zetterberg H; Pedersen KF; Alves G; Lange J
    Parkinsonism Relat Disord; 2018 Apr; 49():4-8. PubMed ID: 29409704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.
    Wang Y; Yang Z; Le W
    Neurosci Bull; 2017 Oct; 33(5):543-551. PubMed ID: 28762215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How close are we to a breakthrough? The hunt for blood biomarkers in Parkinson's disease diagnosis.
    Liu C; Su Y; Ma X; Wei Y; Qiao R
    Eur J Neurosci; 2024 May; 59(10):2563-2576. PubMed ID: 38379501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
    Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
    BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.
    Majbour NK; Vaikath NN; Eusebi P; Chiasserini D; Ardah M; Varghese S; Haque ME; Tokuda T; Auinger P; Calabresi P; Parnetti L; El-Agnaf OM
    Mov Disord; 2016 Oct; 31(10):1535-1542. PubMed ID: 27548849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.
    van Dijk KD; Teunissen CE; Drukarch B; Jimenez CR; Groenewegen HJ; Berendse HW; van de Berg WD
    Neurobiol Dis; 2010 Sep; 39(3):229-41. PubMed ID: 20451609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.